Diana Nanayakkara
Acute Care · Plano, TXNPI 1710022819
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 364 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Itamar Medical Inc$851
- Novo Nordisk$563
- Amgen$486
- Heartflow, Inc.$485
- Edwards Lifesciences$439
- plus $5K from 31 others
What the payments were for
- Food & beverage$9,11798%
- Entertainment$1592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 78 | $1,484 |
| Itamar Medical Inc | 4 | $851 |
| Novo Nordisk | 30 | $563 |
| Amgen | 34 | $486 |
| Heartflow, Inc. | 7 | $485 |
| Edwards Lifesciences | 3 | $439 |
| Pfizer | 30 | $417 |
| Abiomed | 5 | $369 |
| Johnson & Johnson | 43 | $366 |
| Merck | 19 | $337 |
| Amarin Pharma, Inc. | 17 | $298 |
| Esperion Therapeutics, Inc. | 16 | $292 |
| Boston Scientific | 7 | $286 |
| Jenavalve Technology, Inc. | 1 | $257 |
| Abbott | 4 | $236 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $213 |
| Bayer | 5 | $198 |
| Alnylam Pharmaceuticals Inc. | 4 | $191 |
| E.r. Squibb & Sons, L.L.C. | 4 | $170 |
| Astellas Pharma US Inc | 7 | $137 |
| Lexicon Pharmaceuticals, Inc. | 1 | $122 |
| Recor Medical Inc | 1 | $117 |
| Medtronic | 2 | $111 |
| AstraZeneca | 8 | $107 |
| Boehringer Ingelheim | 7 | $103 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $98 |
| Intuitive Surgical | 1 | $98 |
| Bridgebio Pharma, Inc. | 3 | $90 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Bracco Diagnostics Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Althera Pharmaceuticals LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WatchPat$580
- FFRct$283
- WatchPATONE$271
- Impella$142
- SAPIEN 3 Ultra RESILIA$131
- Edwards SAPIEN 3 Transcatheter Heart Valve$127
- Adempas$125
- VYNDAQEL$125
- AMVUTTRA$125
- Inpefa$122
- AMPLATZER AMULET$119
- Paradise Ultrasound Renal Denervation System$117
- EVKEEZA$116
- NEXLIZET$111
- NEXLETOL$111
- CAMZYOS$109
- Repatha$106
How this compares
$9,276 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 110 | $131,473 |
| EntrestoSacubitril/Valsartan | 65 | $67,138 |
| JardianceEmpagliflozin | 39 | $44,952 |
| XareltoRivaroxaban | 22 | $31,226 |
| BrilintaTicagrelor | 17 | $21,755 |
| Ranolazine ErRanolazine | 41 | $3,794 |
| Metoprolol Succinate | 196 | $3,362 |
| Rosuvastatin Calcium | 190 | $2,684 |
| Nifedipine ErNifedipine | 25 | $1,172 |
| Nebivolol Hcl | 16 | $1,154 |
| ClopidogrelClopidogrel Bisulfate | 74 | $1,087 |
| Olmesartan Medoxomil | 44 | $1,074 |
| Carvedilol | 119 | $1,067 |
| Amlodipine Besylate | 125 | $1,062 |
| Atorvastatin Calcium | 100 | $1,028 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $417 | $131,473110 claims |
| NovartisEntresto | $1,484 | $67,13865 claims |
| Boehringer IngelheimJardiance | $103 | $44,95239 claims |
| Johnson & JohnsonXarelto | $366 | $31,22622 claims |
| AstraZenecaBrilinta | $107 | $21,75517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in Plano
- Jennifer CorralesPlano$13K
- Preethy OommenPlano$13K
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.